It is a research & development private limited company based in Vasant Kunj, New Delhi, Delhi, India, established in 2018.
2018 | Vasant Kunj, New Delhi, Delhi, India | Struck OffCann Future Therapeutics Private Limited, a struck off private limited company, was established on 21 December 2018 in Vasant Kunj, New Delhi, Delhi, India. Engaging in science research within the research & development sector, it holds CIN: U73100DL2018PTC343390. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Shiv Kumar Khandelwal (Director), Ankur Khandelwal (Director). Past directors included Shiv Kumar Khandelwal, Vedant Maheshwari. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Flat No 4, Hig Narmada Block-1, Sec-D, Pkt-6, Vasant Kunj, New Delhi, Delhi, 110070.
U73100DL2018PTC343390
343390
21 December 2018
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Cann Future Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Kumar Khandelwal | Director | 03 Sep 2019 | Current |
| Ankur Khandelwal | Director | 21 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 03 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cann Future Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 54.68% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cann Future Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cann Future Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cann Future Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cann Future Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cann Future Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Cann Future Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was recorded as a recent event.
Shiv Kumar Khandelwal was appointed as a Director was appointed as a Director on 03 Sep 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.
The activity Ankur Khandelwal was appointed as a Director was appointed as a Director on 21 Dec 2018 & has been associated with this company since 6 years 11 months . was completed.
Cann Future Therapeutics Private Limited was registered on 21 Dec 2018 with Roc Delhi & aged 6 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Cann Future Therapeutics Private Limited is U73100DL2018PTC343390.
Cann Future Therapeutics Private Limited is headquartered at Flat No 4, Hig Narmada Block-1, Sec-D, Pkt-6, Vasant Kunj, New Delhi, Delhi, 110070.
Cann Future Therapeutics Private Limited was incorporated on 21 December 2018.
The current directors of Cann Future Therapeutics Private Limited are
The primary industry of Cann Future Therapeutics Private Limited is Research & Development.
Cann Future Therapeutics Private Limited is unlisted.
The authorized capital of Cann Future Therapeutics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX